ZENAS
Ropes & Gray endorses open market sale of $200M Zenas shares
Zenas BioPharma filed a supplemental legal opinion supporting the sale of up to $200 million in common stock under an existing open market agreement. This regulatory approval facilitates the continued liquidity program for the company's shares.